Drug Profile
Research programme: beta-2 adrenergic receptor agonists - Pfizer
Alternative Names: Compound X; UK 503590Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma in United Kingdom (Inhalation, Inhalant)
- 08 Oct 2008 Final pharmacodynamics data from a preclinical trial in Asthma presented at the 18th Annual Congress of the European Respiratory Society (ERS-2008)
- 21 May 2008 Preclinical trials in Asthma in United Kingdom (Inhalation)